154 related articles for article (PubMed ID: 11896935)
1. Contribution of HLA class I allele expression to CD8+ T-cell responses against Epstein-Barr virus.
Höllsberg P
Scand J Immunol; 2002 Feb; 55(2):189-95. PubMed ID: 11896935
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection.
Akram A; Inman RD
Eur J Immunol; 2013 Dec; 43(12):3254-67. PubMed ID: 24113999
[TBL] [Abstract][Full Text] [Related]
3. The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.
Jones K; Wockner L; Brennan RM; Keane C; Chattopadhyay PK; Roederer M; Price DA; Cole DK; Hassan B; Beck K; Gottlieb D; Ritchie DS; Seymour JF; Vari F; Crooks P; Burrows SR; Gandhi MK
Clin Exp Immunol; 2016 Feb; 183(2):206-20. PubMed ID: 26422112
[TBL] [Abstract][Full Text] [Related]
4. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
Turcanová V; Höllsberg P
J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
[TBL] [Abstract][Full Text] [Related]
5. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
6. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
Höllsberg P; Hansen HJ; Haahr S
Clin Exp Immunol; 2003 Apr; 132(1):137-43. PubMed ID: 12653848
[TBL] [Abstract][Full Text] [Related]
7. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
Jilek S; Schluep M; Harari A; Canales M; Lysandropoulos A; Zekeridou A; Pantaleo G; Du Pasquier RA
J Immunol; 2012 May; 188(9):4671-80. PubMed ID: 22461701
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus Epitope-Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires.
Gil A; Kamga L; Chirravuri-Venkata R; Aslan N; Clark F; Ghersi D; Luzuriaga K; Selin LK
mBio; 2020 Mar; 11(2):. PubMed ID: 32184241
[TBL] [Abstract][Full Text] [Related]
9. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
[TBL] [Abstract][Full Text] [Related]
10. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
[TBL] [Abstract][Full Text] [Related]
11. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.
Catalina MD; Sullivan JL; Bak KR; Luzuriaga K
J Immunol; 2001 Oct; 167(8):4450-7. PubMed ID: 11591771
[TBL] [Abstract][Full Text] [Related]
12. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
[TBL] [Abstract][Full Text] [Related]
13. Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design.
Bharadwaj M; Sherritt M; Khanna R; Moss DJ
Vaccine; 2001 Jun; 19(27):3769-77. PubMed ID: 11395212
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
15. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
Khanna R; Burrows SR; Nicholls J; Poulsen LM
Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
[TBL] [Abstract][Full Text] [Related]
16. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.
Yu XG; Addo MM; Rosenberg ES; Rodriguez WR; Lee PK; Fitzpatrick CA; Johnston MN; Strick D; Goulder PJ; Walker BD; Altfeld M
J Virol; 2002 Sep; 76(17):8690-701. PubMed ID: 12163589
[TBL] [Abstract][Full Text] [Related]
17. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.
Tsang KY; Zaremba S; Nieroda CA; Zhu MZ; Hamilton JM; Schlom J
J Natl Cancer Inst; 1995 Jul; 87(13):982-90. PubMed ID: 7629885
[TBL] [Abstract][Full Text] [Related]
18. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC
Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.
Terajima M; Orphin L; Leporati AM; Pazoles P; Cruz J; Rothman AL; Ennis FA
Hum Immunol; 2008 Dec; 69(12):815-25. PubMed ID: 18955096
[TBL] [Abstract][Full Text] [Related]
20. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein.
Bryden H; MacKenzie J; Andrew L; Alexander FE; Angus B; Krajewski AS; Armstrong AA; Gray D; Cartwright RA; Kane E; Wright DH; Taylor P; Jarrett RF
Int J Cancer; 1997 Aug; 72(4):614-8. PubMed ID: 9259400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]